New Tax Rules Won’t Stop Pfizer From Bidding U.S. Goodbye
This article is for subscribers only.
The U.S. attempt to block companies from leaving the country for tax reasons wouldn’t stop Pfizer Inc. from moving America’s biggest drugmaker overseas if it finds an attractive deal, Chief Executive Officer Ian Read said.
“If we believe the value is still there and we believe, under our interpretation of these rules, there is still value, I see no reason why we wouldn’t be able to do an inversion,” Read said yesterday in a telephone interview.